[Methods and results of catheter electrodestruction in treating tachyarrhythmias]

Kardiologiia
|May 1, 1987
PubMed

Insights

Catheter electrofulguration effectively treated drug-resistant supraventricular and ventricular tachycardias in 56 patients. This minimally invasive procedure achieved long-term success in 52 patients, offering a viable alternative to traditional therapies.

Area of Science:

  • Electrophysiology
  • Cardiology

Context:

  • Supraventricular and ventricular tachycardias pose significant challenges in treatment.
  • Conservative management often proves insufficient for refractory cases.

Purpose:

  • To evaluate the efficacy and outcomes of catheter electrofulguration for treating tachyarrhythmias resistant to conventional therapies.

Summary:

  • Catheter electrofulguration was performed on 56 patients with refractory tachycardias.
  • Transvenous His bundle and AV junction ablation in 40 patients resulted in complete AV block and pacemaker implantation in 39.
  • Radical surgery targeting atrial, AV junction, or ventricular arrhythmogenic zones in 16 patients showed high success rates.
  • Overall, 52 patients experienced complete resolution of tachyarrhythmias during 6 months to 3.5 years of follow-up.

Impact:

  • Catheter electrofulguration offers a successful therapeutic option for patients with complex tachyarrhythmias.
  • This approach can significantly improve patient outcomes and quality of life.
  • The study highlights the potential of electrofulguration as a minimally invasive alternative to more aggressive surgical interventions.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...